Evolent Health, Inc.
DE ˙ DB ˙ US30050B1017
3,38 € ↓ -0,16 (-4,52%)
2026-06-03
AKTIENPREIS
SecurityDE:9EH / Evolent Health, Inc.
InstitutionBlair William & Co/il
Latest Disclosed Ownership35,039 shares
Latest Disclosed Value $ 79,889
Blair William & Co/il ownership in 9EH / Evolent Health, Inc.

On May 8, 2026 - Blair William & Co/il filed a 13F-HR form disclosing ownership of 35,039 shares of Evolent Health, Inc. (DE:9EH) valued at $66,224 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 43,206 shares of Evolent Health, Inc.. This represents a change in shares of -18.90% during the quarter. The current value of the position is $118,432 USD.

Blair William & Co/il has a history of taking positions in derivatives of the underlying security (9EH) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:9EH / Evolent Health, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F EVOLENT HEALTH CL A 30050B101 35,039 -8,167 -18.90 80 -54.07 0.0002
2026-02-17 2025-12-31 13F EVOLENT HEALTH CL A 30050B101 43,206 -395,725 -90.16 173 -95.37 0.0005
2025-11-12 2025-09-30 13F EVOLENT HEALTH CL A 30050B101 438,931 -5,343 -1.20 3,713 -25.77 0.0099
2025-07-24 2025-06-30 13F EVOLENT HEALTH CL A 30050B101 444,274 -180,366 -28.88 5,003 -15.44 0.0139
2025-05-09 2025-03-31 13F EVOLENT HEALTH CL A 30050B101 624,640 -1,034,348 -62.35 5,915 -68.31 0.0178
2025-02-12 2024-12-31 13F EVOLENT HEALTH CL A 30050B101 1,658,988 -497,127 -23.06 18,664 -69.39 0.0543
2024-11-12 2024-09-30 13F EVOLENT HEALTH CL A 30050B101 2,156,115 -425,962 -16.50 60,975 23.51 0.1791
2024-08-12 2024-06-30 13F EVOLENT HEALTH CL A 30050B101 2,582,077 -687,142 -21.02 49,369 -53.95 0.1523
2024-05-09 2024-03-31 13F EVOLENT HEALTH CL A 30050B101 3,269,219 229,062 7.53 107,198 6.75 0.3367
2024-02-12 2023-12-31 13F EVOLENT HEALTH CL A 30050B101 3,040,157 189,150 6.63 100,416 29.35 0.3422
2023-11-09 2023-09-30 13F EVOLENT HEALTH CL A 30050B101 2,851,007 399,884 16.31 77,633 4.53 0.2977
2023-08-11 2023-06-30 13F EVOLENT HEALTH CL A 30050B101 2,451,123 102,540 4.37 74,269 -2.55 0.2721
2023-05-12 2023-03-31 13F EVOLENT HEALTH CL A 30050B101 2,348,583 -22,776 -0.96 76,212 14.45 0.3044
2023-02-10 2022-12-31 13F EVOLENT HEALTH CL A 30050B101 2,371,359 18,779 0.80 66,588 -21.22 0.2895
2022-11-09 2022-09-30 13F EVOLENT HEALTH CL A 30050B101 2,352,580 23,645 1.02 84,528 18.18 0.3882
2022-08-10 2022-06-30 13F EVOLENT HEALTH CL A 30050B101 2,328,935 -37,931 -1.60 71,522 -6.45 0.3173
2022-05-13 2022-03-31 13F EVOLENT HEALTH CL A 30050B101 2,366,866 -112,959 -4.56 76,450 11.42 0.2680
2022-02-14 2021-12-31 13F EVOLENT HEALTH CL A 30050B101 2,479,825 -78,360 -3.06 68,617 -13.48 0.2152
2021-11-12 2021-09-30 13F EVOLENT HEALTH CL A 30050B101 2,558,185 39,296 1.56 79,304 49.07 0.2700
2021-08-12 2021-06-30 13F EVOLENT HEALTH CL A 30050B101 2,518,889 127,207 5.32 53,199 10.12 0.1843
2021-05-13 2021-03-31 13F EVOLENT HEALTH CL A 30050B101 2,391,682 71,795 3.09 48,312 29.91 0.1823
2021-02-09 2020-12-31 13F EVOLENT HEALTH CL A 30050B101 2,319,887 15,480 0.67 37,188 30.04 0.1363
2020-11-06 2020-09-30 13F EVOLENT HEALTH CL A 30050B101 2,304,407 -220,749 -8.74 28,598 59.06 0.1213
2020-08-12 2020-06-30 13F EVOLENT HEALTH CL A 30050B101 2,525,156 1,621,400 179.41 17,979 266.39 0.0857
2020-05-11 2020-03-31 13F EVOLENT HEALTH CL A 30050B101 903,756 -257,972 -22.21 4,907 -53.33 0.0307
2020-02-13 2019-12-31 13F EVOLENT HEALTH CL A 30050B101 1,161,728 152,305 15.09 10,514 44.86 0.0540
2019-11-12 2019-09-30 13F EVOLENT HEALTH CL A 30050B101 1,009,423 -207,917 -17.08 7,258 -25.01 0.0418
2019-08-13 2019-06-30 13F EVOLENT HEALTH CL A 30050B101 1,217,340 -159,278 -11.57 9,678 -44.12 0.0553
2019-05-14 2019-03-31 13F EVOLENT HEALTH CL A 30050B101 1,376,618 -649,268 -32.05 17,318 -57.15 0.1056
2019-02-14 2018-12-31 13F EVOLENT HEALTH CL A 30050B101 2,025,886 -115,385 -5.39 40,416 -33.54 0.2952
2018-11-13 2018-09-30 13F EVOLENT HEALTH CL A 30050B101 2,141,271 -43,063 -1.97 60,812 32.26 0.3726
2018-08-13 2018-06-30 13F EVOLENT HEALTH CL A 30050B101 2,184,334 -293,970 -11.86 45,980 30.20 0.3127
2018-05-15 2018-03-31 13F EVOLENT HEALTH CL A 30050B101 2,478,304 -489,940 -16.51 35,316 -3.27 0.2497
2018-02-14 2017-12-31 13F EVOLENT HEALTH CL A 30050B101 2,968,244 -170,516 -5.43 36,509 -34.65 0.2478
2017-11-13 2017-09-30 13F EVOLENT HEALTH INC - A COM 30050B101 3,138,760 953,065 43.60 55,870 0.84 0.4190
2017-08-04 2017-06-30 13F EVOLENT HEALTH INC - A COM 30050B101 2,185,695 523,674 31.51 55,407 69.22 0.4160
2017-05-10 2017-03-31 13F EVOLENT HEALTH INC COM 30050B101 1,662,021 113,198 7.31 32,742 42.83 0.2639
2017-02-14 2016-12-31 13F EVOLENT HEALTH INC COM 30050B101 1,548,823 904,661 140.44 22,923 44.54 0.2050
2016-11-14 2016-09-30 13F EVOLENT HEALTH INC ADR 30050B101 644,162 302,592 88.59 15,859 141.83 0.1402
2016-08-08 2016-06-30 13F Evolent Health ADR 30050B101 341,570 229,748 205.46 6,558 455.29 0.0611
2016-05-16 2016-03-31 13F EVOLENT HEALTH INC - A COM 30050B101 111,822 111,822 1,181 0.0111
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2017-08-04 2017-06-30 13F EVOLENT HEALTH INC OPTION Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-05-10 2017-03-31 13F EVOLENT HEALTH INC OPTION Call 800 18 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.